Pappas Capital

Pappas Capital is a venture capital firm fostering innovative life science companies. It provides strategic capital and guidance to enterprises developing advanced products across biopharma, biotechnology, and medical devices. The firm’s approach emphasizes identifying and nurturing groundbreaking solutions for human diseases, moving discoveries from concept to market for improved patient outcomes.

Arthur M. Pappas founded Pappas Capital in 1994, leveraging his extensive executive experience in pharmaceutical and biotechnology sectors. His insight recognized the critical need for specialized capital and seasoned leadership to guide emerging life science ventures through complex development and commercialization. This expertise shaped the firm's strategic focus on health innovation.

The firm serves innovative life science companies seeking funding and limited partners pursuing specialized investment opportunities. Pappas Capital's long-term vision is to propel next-generation health advancements by bringing transformative solutions to market. They are committed to improving global patient outcomes through strategic investments in biopharma, biotech, and medical technologies.